Discover 1,846 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Whether you're a healthy volunteer interested in paid studies or someone looking for trials focused on specific conditions, Tennessee offers a wide variety of clinical research options. Leading facilities in Nashville, Memphis, and Knoxville are currently seeking participants, providing opportunities for individuals to access innovative treatments and specialized healthcare.
Filter
1
Filter results
Results: 1,846
Mechanically Optimizing Cardiac Preload in Heart Failure Patients
for
Heart Failure
Location: Nashville TN
Sponsor: Cardioflow Technologies, LLC
Sex: All
Age: 18 - 70+
Code: NCT04338503
Recruiting
Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation
for
Wilms Tumor
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0+
Code: NCT04968990
Phase2, Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Saint John, Damariscotta ME, Brunswick ME, Augusta ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04269902
Phase3, Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
for
Childhood Medulloblastoma
Location: Halifax, Boston MA, Providence RI, Hartford CT,
Sponsor: Children's Oncology Group
Sex: All
Age: 4 - 21
Code: NCT05382338
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS)
for
Stress Urinary Incontinence (SUI)
Location: Virginia Beach VA, Durham NC, Charlotte NC,
Sponsor: UroMems SAS
Sex: Male
Age: 22+
Code: NCT06968741
Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer,
Location: Newark DE, Baltimore MD, Washington D.C. DC,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07154290
Phase2, Recruiting
ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
for
NMIBC
Location: Cynwyd PA, Troy MI, Atlanta GA, Nashville TN,
Sponsor: ImmunityBio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06800963
Phase1, Phase2, Recruiting
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
for
Locally Advanced Breast Cancer, Unresectable Breast Carcinoma,
Location: New York NY, Stony Brook NY, Chicoutimi, Uniondale NY,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06827236
Phase1, Phase2, Recruiting
Rett Syndrome Registry
for
Rett Syndrome, Rett Syndrome, Atypical, Genetic Disease,
Location: Boston MA, Philadelphia PA, Baltimore MD,
Sponsor: International Rett Syndrome Foundation
Sex: All
Age: 0 - 70+
Code: NCT05432349
Recruiting
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: PMV Pharmaceuticals, Inc
Sex: All
Age: 12+
Code: NCT04585750
Phase1, Phase2, Recruiting
Pan Tumor Rollover Study
for
Cancer
Location: Boston MA, Mineola NY, Lancaster PA, Toronto,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT03899155
Phase2, Recruiting
Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial
for
Post-ligation Cardiac Syndrome
Location: Boston MA, Philadelphia PA, Durham NC, Cleveland OH,
Sponsor: NICHD Neonatal Research Network
Sex: All
Age: 0
Code: NCT06679855
Phase3, Recruiting
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
for
NSCLC Stage IV
Location: Saint John, Richmond VA, Fairfax VA, Fort Lauderdale FL,